Preliminary results of a clinical trial for the chemotherapy drug docetaxel indicate that hormone-sensitive metastatic prostate cancer patients who added hormone therapy to the mix experienced significantly prolonged survival, according to a Dec. 5 statement by the National Institutes of Health (NIH).

A new imaging agent is showing potential for the early detection of Parkinson’s disease (PD) by identifying a functional loss of dopamine neurons, according to a study published online Nov. 28 by the Journal of Nuclear Medicine.

The current global market for molecular imaging technology is estimated at $2.2 billion this year and is expected to increase at a compound annual growth rate of 6.2 percent, according to a November 2013 market research report from BCC Research.

The availability of prior examinations and digital breast tomosynthesis (DBT) are independent primary factors in reducing recall recommendations during mammographic interpretations, according to a study published online Dec. 6 in Academic Radiology.

As breast cancer screening modalities evolve, policies and best practices must be determined for the latest technology, digital breast tomosynthesis (DBT), according to an article published in the December issue of the Journal of the American College of Radiology.

More than 18 percent of all lung cancers detected with low-dose CT screening (LDCT) are overdiagnosed, according to a study published by JAMA Internal Medicine on Dec. 9. 

New data regarding the prevalence of Alzheimer's disease is looming far and above previous estimates: 17 percent higher than previously thought, according to statistics from Alzheimer's Disease International.

CHICAGO--The quest for a clear way forward in neurodegenerative imaging and therapeutics continues, with many of the same challenges continuing from previous years, according to a neuroimaging symposium during the Radiological Society of North America’s (RSNA) 99th annual meeting.